Cancer Aware · Patient & Family Guide

Understanding Endometrial Cancer

Endometrial cancer begins in the lining of the uterus. Understanding where it starts helps make sense of bleeding, biopsy results and the treatments your team discusses.

Educational information for patients and families. This guide supports, but does not replace, individualized medical advice. It cannot diagnose, stage cancer or prescribe treatment.

All 25 chapters

Chapter 1 of 25

Uterine lining and muscle, simplified cross-sectionThe endometrium lines the central cavity. The myometrium surrounds it. The cervix connects the uterus to the vagina. Not to scale.Endometrium(lining)Myometrium(muscle)CervixVagina
Conceptual anatomy, not to scale. Endometrial cancer begins in the lining; cervical cancer and pure uterine sarcoma are different diseases.

What you will learn

  • Identify the endometrium, uterine muscle and cervix.
  • Distinguish endometrial carcinoma from other uterine cancers.
  • Understand why pathology and molecular tests are needed together.

The uterus and its lining

The uterus, also called the womb, is a muscular organ in the pelvis, between the bladder and rectum. Its inner lining is the endometrium. Before menopause this lining usually grows and sheds in response to changing hormones, producing menstrual bleeding. The thick muscle around it is the myometrium. The cervix is the lower opening into the vagina; it has different cells and a different cancer-prevention pathway.

Cancer develops when changes in cells allow uncontrolled growth. Endometrial cancer usually starts in the glands of the lining. A tumour may remain near the surface, grow into the myometrium, enter small lymphatic or blood vessels, or spread elsewhere. These are possibilities, not an inevitable sequence for every person. The depth of muscle invasion and any spread help determine treatment after surgery.

Similar names, different diseases

TermWhat it meansWhy the distinction matters
Endometrial carcinomaCancer arising from the uterine liningThis guide's main subject
Cervical cancerCancer beginning in the cervixHPV prevention, staging and treatment differ
Uterine sarcomaCancer arising in muscle or supporting tissueRequires a separate specialist pathway
CarcinosarcomaAggressive carcinoma with carcinoma-like and sarcoma-like componentsStaged and generally treated within endometrial carcinoma pathways

“Uterine cancer” is an umbrella term, so ask for the full diagnosis rather than relying on that phrase. Endometrial cancer is not usually caused by HPV. A normal cervical screening result does not exclude it, and HPV vaccination is not an endometrial cancer vaccine. People who have a uterus can develop this disease regardless of gender identity; care should respect personal language and preferences.

Common and uncommon types

Endometrioid carcinoma is the most common histological type. Histology means the appearance of tissue under a microscope. Many endometrioid cancers are lower grade and found while confined to the uterus, but some are high grade or have spread. Less common types include serous, clear cell, undifferentiated and dedifferentiated carcinoma, and carcinosarcoma. The name alone does not reveal everything about an individual's outlook.

Modern assessment adds molecular classification: POLE-mutated, mismatch repair deficient, p53-abnormal or no specific molecular profile. These describe biological patterns inside the tumour. They can explain why two cancers that look similar behave differently. Molecular results do not replace the assessment of where the cancer is or a discussion of the person's health and priorities.

The first steps after diagnosis

A biopsy establishes the tissue diagnosis. Imaging may then help plan an operation or another treatment. For many people, surgery both removes the cancer and supplies the information needed for final staging. Some need radiotherapy, chemotherapy, immunotherapy or other medicines; many with low-risk disease need no additional treatment after surgery. “Cancer treatment” therefore does not automatically mean chemotherapy.

Keep copies of the biopsy, imaging, operation and molecular reports. Ask who will coordinate results and when the multidisciplinary team will discuss them. A short interval to obtain essential information is different from being lost to follow-up; obtain a named contact if appointments are unclear.

Misconceptions and questions

Is cancer always painful? No. Unusual bleeding may be the first or only symptom. Is it my fault? No. Risk factors describe probabilities and do not assign blame. Can it be cured? Many cancers diagnosed at an early stage are treated with curative intent, but an individual assessment needs the complete results.

Take-home messages

  • The lining and muscle of the uterus are different structures.
  • Confirm the exact histological and molecular diagnosis.
  • Ask which results are still needed before a treatment plan is final.

Related chapters

References and review status

Evidence/editorial check: 30 October 2026. Individual physician review is not recorded. Local approvals, resources and clinical guidance must be confirmed by the treating team.

Evidence scope and update policy